Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-28T00:39:20.107Z Has data issue: false hasContentIssue false
  • English
  • Français

De novo aortopathy and cardiovascular outcomes in paediatric liver transplant recipients

Published online by Cambridge University Press:  29 June 2018

James G. Huang ,
Terence Lim ,
Swee-Chye Quek ,
Seng-Hock Quak  and
Marion M. Aw
James G. Huang*
Affiliation:
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore, Singapore
Terence Lim
Affiliation:
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore, Singapore
Swee-Chye Quek
Affiliation:
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore, Singapore
Seng-Hock Quak
Affiliation:
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore, Singapore
Marion M. Aw
Affiliation:
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore, Singapore
*
Author for correspondence: J. G. Huang, Department of Paediatrics, National University Health System, NUHS Tower Block Level 12, 1E Kent Ridge Road, Singapore 119228, Singapore. Tel: 65 6772 4420; Fax: 65 6779 7486; E-mail: james_huang@nuhs.edu.sg
Get access Rights & Permissions [Opens in a new window]

Abstract

With the increase in long-term survival of post-transplant children, there is a paradigm shift in the emphasis of post-transplant care. We describe de novo cardiovascular abnormalities, which occurred in otherwise asymptomatic paediatric liver transplant recipients, who received liver allografts between 1991 and 2014 at the National University Hospital, Singapore, detected during routine post-transplant monitoring. A total of 96 paediatric liver transplants were performed in 90 children. After transplant, 7/90 (7.8%) recipients were identified with new-onset aortopathy. Glycogen storage disease type I (42.9% versus 2.4%; p<0.001) and recipient Epstein-Barr virus seropositivity (85.7 versus 31.0%, p=0.004) were significant risk factors for aortopathy on univariate analysis. On multivariate analysis, only glycogen storage disease type I remained as the significant risk factor (odds ratio 51.3 [95% confidence intervals: 1.1–2498.1, p=0.047]). Liver transplant is a double-edged sword that reverses certain cardiopulmonary complications of end-stage liver disease but may induce de novo structural cardiac injury in the form of aortic dilation.

Keywords

Liver transplant recipientspaediatricaortopathycardiaccardiovascular
Type
Original Article
Information
Cardiology in the Young , Volume 28 , Issue 8 , August 2018 , pp. 986 - 994
Check for updates
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Huang JG, Lim T, Quek S-C, Quak S-H, Aw MM. (2018) De novo aortopathy and cardiovascular outcomes in paediatric liver transplant recipients. Cardiology in the Young28: 986–994. doi: 10.1017/S104795111800063X

References

1. Soltys, KA, Mazariegos, GV, Squires, RH, Sindhi, RK, Anand, R. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007; 7: 2165–2171.CrossRefGoogle ScholarPubMed
2. Magee, J, Krishnan, S, Benfield, M, Hsu, D, Shneider, B. Pediatric transplantation in the United States, 1997-2006. Am J Transplant 2008; 8: 935–945.Google Scholar
3. Bucuvalas, J. Long-term outcomes in pediatric liver transplantation. Liver Transpl 2009; 15: S6–S11.Google Scholar
4. Ng, VL, Otley, AR. Understanding quality of life for children after liver transplantation: a work in progress. Liver Transpl 2008; 14: 415–417.Google Scholar
5. Fussner, L, Heimbach, J, Fan, C, et al. Cardiovascular disease after liver transplantation: when, what, and who is at risk. Liver Transpl 2015; 21: 889–896.Google Scholar
6. Baskar, S, George, PL, Eghtesad, B, et al. Cardiovascular risk factors and cardiac disorders in long-term survivors of pediatric liver transplantation. Pediatr Transplant 2015; 19: 48–55.CrossRefGoogle ScholarPubMed
7. Atkison, P, Joubert, G, Barron, A, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 1995; 345: 894–896.Google Scholar
8. Kotb, MA, Abd El Satar, I, Badr, AM, et al. Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation. J Adv Res 2017; 8: 663–668.Google Scholar
9. Pettersen, MD, Du, W, Skeens, ME, Humes, RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 2008; 21: 922–934.Google Scholar
10. Gautier, M, Detaint, D, Fermanian, C, et al. Nomograms for aortic root diameters in children using two-dimensional echocardiography. Am J Cardiol 2010; 105: 888–894.Google Scholar
11. Fernandes, S, Khairy, P, Graham, DA, et al. Bicuspid aortic valve and associated aortic dilation in the young. Heart 2012; 98: 1014e1019.Google Scholar
12. Schwartz, GJ, Work, DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 2009; 4: 1832–1843.Google Scholar
13. Staples, A, LeBlond, R, Watkins, S, Wong, C, Brandt, J. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol 2010; 25: 2321–2326.Google Scholar
14. Stevens, LA, Claybon, MA, Schmid, CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 2011; 79: 555–562.Google Scholar
15. Flynn, JT, Kaelber, DC, Baker-Smith, CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: e20171904.Google Scholar
16. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 495–501.Google Scholar
17. Lee, YS, Biddle, S, Chan, MF, et al. Health promotion board–ministry of health clinical practice guidelines: obesity. Singapore Med J 2016; 57: 292–300.Google Scholar
18. Moller, S, Henriksen, JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9–15.Google Scholar
19. Zardi, EM, Zardi, DM, Chin, D, Sonnino, C, Dobrina, A, Abbate, A. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. J Cardiol 2016; 67: 125–130.Google Scholar
20. Henderson, JM, Mackay, GJ, Hooks, M, et al. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology 1992; 15: 258–262.CrossRefGoogle ScholarPubMed
21. Zarate, Y, Sellars, E, Lepard, T, Carlo, W, Tang, X, Collins, R 2nd. Aortic dilation in pediatric patients. Eur J Pediatr 2015; 174: 1585–1592.Google Scholar
22. Gupta-Malhotra, M, Devereux, RB, Dave, A, Bell, C, Portman, R, Milewicz, D. Aortic dilatation in children with systemic hypertension. J Am Soc Hypertens 2014; 8: 239–245.Google Scholar
23. Kaddourah, A, Uthup, S, Madueme, P, et al. Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease. Clin Nephrol 2015; 83: 262–271.Google Scholar
24. McLin, VA, Anand, R, Daniels, SR, Yin, W, Alonso, EM. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant 2012; 12: 183–190.Google Scholar
25. Sorof, JM, Lai, D, Turner, J, Poffenbarger, T, Portman, RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004; 113: 475–482.Google Scholar
26. Ng, VL, Fecteau, A, Shepherd, R, et al. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American Multicenter Registry. Pediatrics 2008; 122: e1128–e1135.Google Scholar
27. Perito, E, Glidden, D, Roberts, J, Rosenthal, P. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987-2010. Pediatr Transplant 2012; 16: 41–49.CrossRefGoogle Scholar
28. Kishnani, PS, Austin, SL, Abdenur, JE, et al. Diagnosis and management of glycogen storage disease type I. Genet Med 2014; 16: 1.Google Scholar
29. Iyer, SG, Chen, CL, Wang, CC, et al. Long‐term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl 2007; 13: 848–852.Google Scholar
30. Maheshwari, A, Rankin, R, Segev, DL, Thuluvath, PJ. Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature. Clin Transplant 2012; 26: 432–436.Google Scholar
31. Yekeler, E, Dursun, M, Emeksiz, E, et al. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Turk J Pediatr 2007; 49: 115–119.Google Scholar
32. Bernier, AV, Correia, CE, Haller, MJ, Theriaque, DW, Shuster, JJ, Weinstein, DA. Vascular dysfunction in glycogen storage disease type I. J Pediatr 2009; 154: 588–591.Google Scholar
33. Lee, P, Celermajer, D, Robinson, J, McCarthy, S, Betteridge, D, Leonard, J. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 1994; 110: 95–100.CrossRefGoogle Scholar
34. Li, L, Krantz, ID, Deng, Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16: 243–251.Google Scholar
35. Ozcay, F, Varan, B, Tokel, K, Cetin, I, Dalgic, A, Haberal, M. Severe peripheral pulmonary artery stenosis is not a contraindication to liver transplantation in Alagille syndrome. Pediatr Transplant 2006; 10: 108–111.Google Scholar
36. Al-Hamoudi, W. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol 2009; 16: 145–153.Google Scholar
37. Turkbey, EB, Jain, A, Johnson, C, et al. Determinants and normal values of ascending aortic diameter by age, gender, and race/ethnicity in the Multi-Ethnic Study of Atherosclerosis (MESA). J Magn Reson Imaging 2014; 39: 360–368.Google Scholar
38. Rosca, MG, Hoppel, CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev 2013; 18: 607–622.Google Scholar
39. Ballinger, SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005; 38: 1278–1295.Google Scholar
40. Tang, X, Luo, YX, Chen, HZ, Liu, DP. Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 2014; 5: 175.CrossRefGoogle ScholarPubMed
41. Farah, BL, Sinha, RA, Wu, Y, et al. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa). Sci Rep 2017; 7: 44408.CrossRefGoogle ScholarPubMed
42. Palacin, M, Coto, E, Llobet, L, et al. FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. Cell Biol Toxicol 2013; 29: 407–414.Google Scholar
43. Lombardi, A, Trimarco, B, Iaccarino, G, Santulli, G. Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure. Cell Commun Signal 2017; 15: 47.Google Scholar
44. Chen, CJ, Tang, KS, Huang, YH, et al. The characteristics of antioxidant activity after liver transplantation in biliary atresia patients. Biomed Res Int 2015; 2015: 421413.Google ScholarPubMed
45. Chang, RK, McDiarmid, SV, Alejos, JC, Drant, SE, Klitzner, TS. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation. Pediatr Transplant 2001; 5: 187–191.CrossRefGoogle ScholarPubMed
46. Poirier, O, Nicaud, V, McDonagh, T, et al. Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy. Eur J Hum Genet 2003; 11: 659–664.CrossRefGoogle ScholarPubMed
47. Neal, DA, Brown, MJ, Wilkinson, IB, Alexander, GJ. Mechanisms of hypertension after liver transplantation. Transplantation 2005; 79: 935–940.Google Scholar
48. Textor, SC, Taler, SJ, Canzanello, VJ, Schwartz, L, Augustine, JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000; 6: 521–530.CrossRefGoogle ScholarPubMed
49. Vuurmans, TJ, Boer, P, Koomans, HA. Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans. Hypertension 2003; 41: 1253–1258.Google Scholar
50. Chen, R, Wong, S, Wong, W, Cheung, Y. Arterial mechanics at rest and during exercise in adolescents and young adults after arterial switch operation for complete transposition of the great arteries. Am J Cardiol 2014; 113: 713–718.Google Scholar
51. Nollen, GJ, Groenink, M, Tijssen, JG, Van Der Wall, EE, Mulder, BJ. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J 2004; 25: 1146–1152.CrossRefGoogle ScholarPubMed
52. Shalev, A, Nir, A, Granot, E. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Pediatr Transplant 2005; 9: 718–722.Google Scholar